
Mizuho Senior Biotech Analyst Salim Syed highlights key companies in the news he covers heading into the new year
BiotechTV - News
00:00
Arcus and HIF2-alpha potential
Salim praises Arcus' kazdatafin data, forecasts strong combination readouts and multibillion peak sales potential.
Play episode from 26:49
Transcript


